Key result
mtDNA D-loop polymorphisms linked to earlier onset, higher metastasis, and relapse in malignant fibrous histiocytoma.
Why the study?
The association of SNPs in the mitochondrial DNA D-loop with age-at-onset, metastasis, and relapse in malignant fibrous histiocytoma was investigated to identify genetic predictors of clinical outcomes.
Do specific SNPs in the D-loop of mtDNA predict age-at-onset, metastasis, and relapse in patients with malignant fibrous histiocytoma?
Observational
Do specific SNPs in the D-loop of mtDNA predict age-at-onset, metastasis, and relapse in patients with malignant fibrous histiocytoma?
Genetic polymorphisms in the D-loop of mtDNA, specifically at sites 16304, 152, and 16266, may help identify MFH patients at high risk for early onset, metastasis, and relapse.
D-loop SNP associations with MFH outcomes are hypothesis-generating; larger prospective studies needed before any clinical use.
The accumulation of single nucleotide polymorphisms (SNPs) in the displacement loop (D-loop) of mitochondrial DNA (mtDNA) has been described in many cancers. In our previous studies, we have identified cancer risk and outcome associated SNPs in the D-loop of malignant fibrous histiocytoma (MFH). In the present study, we investigated the SNPs in the D-loop of mitochondria DNA (mtDNA) for their association with age-at-onset, metastasis, and relapse using a population-based series of MFH patients. Our data showed that the SNP site of nucleotide 16304 T/C was associated with age-at-onset using the Kaplan–Meier method and compared by the log-rank test. Meanwhile, allele 152C genotype was identified to be significantly associated with a high metastasis rate in MFH patients. In addition, patients with allele 16266C were proven to have a higher relapse rate compared with 16266T at a statistically significant level. Finally, we performed a multivariate analysis with the Cox proportional hazards model. The age-at-onset of patients with the minor allele C genotype was significantly earlier than that of patients with the T genotype at the 16304 site. In summary, the analysis of genetic polymorphisms in the D-loop may help to identify patient subgroups at a high risk of early onset, high metastasis and relapse rate in MFH, thereby helping to refine therapeutic decisions.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2019) conducted an observational in Malignant fibrous histiocytoma (MFH). Single nucleotide polymorphisms (SNPs) in the D-loop of mitochondrial DNA (mtDNA) vs. Alternative alleles (e.g., T genotype at 16304 site, 16266T) was evaluated on Age-at-onset, metastasis, and relapse. Mitochondrial DNA D-loop polymorphisms (16304C, 152C, 16266C) were significantly associated with earlier age-at-onset, higher metastasis, and higher relapse rates in malignant fibrous histiocytoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: